NBA Law Blog - Neblett Beard & Arsenault » Dangerous Products

CooperVision Expands Contacts Lens Recall to include Avaira Sphere and Avaira Toric

Richard Arsenault — Fri, 18 Nov 2011 19:33:30 +0000

Last month, CooperVision recalled over 750,000 Avaira Toric contact lenses because a silicon oil residue left on the lenses could cause eye injuries. Yesterday, CooperVision extended their previous Avaira recall to include Avaira Sphere lenses. Avaira Toric lenses are only worn by people with astigmatism, and Avaira Sphere lenses are generally worn by people who don’t have astigmatism.

This recent expansion of CooperVision’s previous recall of Avaira Toric Contact Lenses affects 6.6 million contact lenses which may cause side effects such as hazy vision, pain, and eye damage. CBS News reports that the FDA thought CooperVision’s recall didn’t go far enough, and that’s why the FDA has issued “its own urgent warning about Avaira lenses”.

According-+ to the FDA, levels of a silicon oil residue found on the surface of contact lenses causes these eye problems. The world-wide recall involves lenses distributed to several countries including the United States, Canada, Australia, Spain, Hong Kong, Italy, and Germany. Problems reported by Avaira contact lens wearers include severe eye pain, blurred vision, hazy vision, corneal damage and other vision associated problems.

According to an FDA informational page concerning the recall:

If you wear Avaira Sphere contact lenses and experience any symptoms, CooperVision recommends that you stop wearing the lenses immediately. Contact your eye care practitioner for advice. CooperVision will launch a recall site on Wednesday November 16th for wearers to enter the package lot number found on the contact lens carton or blister label to determine if their lenses have been recalled.

If you have experienced symptoms as a result of these contacts, check with your eye care practitioner immediately. The FDA requests that you report any problems or symptoms via their MedWatch Reporting program.

Avaira Toric Contact Lens Recall

Richard Arsenault — Mon, 24 Oct 2011 19:50:30 +0000

Toric contact lenses provide astigmatism sufferers with an effective alternative to glasses. Convenience, appearance, and easy of utilization are all benefits associated with contact lens usage. However, CooperVision’s recently instituted a world-wide recall of Avaira Toric Contact Lenses due to side effects such as hazy vision, pain, and eye damage suffered by lens wearers.

According to press releases issued by Cooper, a residue found on the toric lenses causes the eye problems. The world-wide recall involves lenses distributed to several countries including the United States, Canada, Australia, Spain, Hong Kong, Italy, and Germany. Problems reported by toric lens wearers include severe eye pain, blurred vision, hazy vision, corneal damage and other vision associated problems.

According to an FDA informational page concerning the recall:

On August 19, 2011, the firm sent a recall notification letter to the US and Canadian distributors and health care practitioners. Other foreign distributors were sent the recall letter a week later.

Consumers should return their lenses to their eye care practitioner if they have the affected contact lenses. In addition, if a consumer who is wearing Avaira Toric contact lenses and experiences any symptoms, it is recommended that they stop wearing the lenses immediately and contact their eye care practitioner for advice.

If a consumer is wearing Avaira Toric contact lenses and is NOT experiencing symptoms, Cooper Vision recommends going to their recall web page at www.coopervision.com/recall and enter the lot number of their package to determine whether their lenses have been recalled. If the lenses are on the recall list, they should immediately remove their existing lenses, discontinue all lens wear, and return them to their eye care practitioner or point of purchase.

If you have experienced symptoms as a result of these contacts, check with your doctor immediately. If you are uncertain if your contacts were part of this recall, visit the CooperVision website for additional information.

Nostrilla Nasal Decongestant Spray Recalled Due to Possible Bacterial Contamination

edufour — Fri, 21 Oct 2011 18:17:50 +0000

The following was posted by the FDA.

Insight Pharmaceuticals, LLC of Langhorne, Pa., is recalling one lot (34,092 bottles) of Nostrilla Nasal Decongestant nasal spray to the consumer level, because it may contain the bacteria Burkholderia cepacia.

Burkholderia cepacia may cause serious infection in individuals with a compromised immune system or chronic lung condition (i.e. cystic fibrosis). However, the possibility of infection is remote in healthy individuals.

Nostrilla Nasal Decongestant, lot #11G075, UPC Code 6373673005, was distributed nationwide through normal retail outlets and pharmacies. The product comes in a 1/2 ounce, plastic bottle marked with lot #11G075 on the label and with an expiration date of 05/2014 stamped on the side. No illnesses have been reported to date in connection with this problem.

The recall was initiated following internal investigations which determined the potential presence of a microbial contaminant that exceeds the product specifications and may consequently result in a subpar product. This contaminant has been found sporadically throughout only the respective manufacturing lot, #11G075.

FDA Posts the Following Recall on Cooper Vision Avaira Toric Contact Lenses

Richard Arsenault — Thu, 20 Oct 2011 18:25:17 +0000

In full cooperation with the United States Food and Drug Administration, CooperVision, Inc. is continuing to work with the FDA, distributors, customers, eye care practitioners and lens wearers to complete the worldwide recall initiated on August 19, 2011 on certain lots of Avaira™ Toric contact lenses.

“Our first priority is always the health and safety of all CooperVision lens wearers and as such we responded quickly to complaints from our customers by initiating a voluntary recall” said Christine Moench, vice president, Global Regulatory Affairs and Quality Assurance. “We want to ensure that all consumers are aware of this action and know where to go for more information.”

If you wear Avaira Toric contact lenses and experience any symptoms, CooperVision recommends that you stop wearing the lenses immediately. Contact your eye care practitioner for advice.

The recall was initiated because of the unintended presence of a residue on certain lots of Avaira Toric lenses, which may cause hazy vision, discomfort, or eye injuries requiring medical treatment. Not everyone experiences the same symptoms. Since the initiation of the recall, the company has received some additional complaints of severe eye pain. Avaira Toric contact lens wearers that experience any symptoms should stop wearing the lenses immediately and speak with their eye care practitioner.

We have ongoing relationships with practitioners to continue to identify all the affected lots in the market. To date, the recall has impacted approximately 600,000 Avaira Toric contact lenses in the U.S.

Richard J. Arsenault Chairs Litigation Conference in San Francisco

Neblett Beard & Arsenault — Thu, 28 Jul 2011 18:18:12 +0000

Attorney Richard J. Arsenault, founding and senior partner of Neblett, Beard & Arsenault, served as co-chair at HarrisMartin Publishing’s Zimmer NexGen Knee and DePuy Hip Implant Litigation Conference. In addition to chairing the event, Arsenault also gave a presentation entitled, “Discovery Update – ASR and Pinnacle Litigation.”

The event, which was held the day after the latest DePuy MDL Status Conference, welcomed attorneys from across the country who are interested in or actively involved in the Zimmer and DePuy litigation. The faculty was composed of lawyers from some of the best-known and most-respected law firms in the nation.

Arsenault, a veteran of class action and complex litigation, is frequently asked to chair legal conferences on hot legal topics. His firm is actively representing victims who allege their Zimmer NexGen knee implant or DePuy ASR or Pinnacle hip implants were defective.

Neblett, Beard & Arsenault Files Class Action Lawsuit Against DuPont Over Imprelis Herbicide

Neblett Beard & Arsenault — Mon, 25 Jul 2011 15:02:30 +0000

Check out this press release we just sent:

Neblett, Beard & Arsenault is a nationally recognized law firm with over 25 years of experience handling toxic tort litigation. Richard Arsenault, senior and founding partner, has filed a class action lawsuit and is investigating further legal action against DuPont in connection with possible side effects associated with the Imprelis herbicide.

CLEVELAND, OH – July 24, 2011 - (Docket 1:11-cv-01517) Richard J. Arsenault of Neblett, Beard & Arsenault has filed a class action lawsuit against DuPont over reportedly harmful effects linked to their newly introduced “Imprelis” herbicide. The suit was filed on behalf of victims who claim to have suffered extensive and permanent damage to their trees, lawns and gardens after the use of Imprelis.

According to the lawsuit, Imprelis was applied in accordance with the directions supplied by DuPont. Despite the care taken by lawn care professionals, the application of Imprelis is alleged to have resulted in serious and permanent damage to non-targeted vegetation, including mature trees.

“We are hearing from landscaping professionals who are fearful that Imprelis could become a tremendous financial problem for the lawn care industry,” said Richard Arsenault, one of the lead lawyers for the plaintiffs. “The troubling dynamic here is that while we don’t yet know how extensive the damage will be, what we’ve seen so far is not encouraging.”

Reports of tree deaths and damage linked to the use of Imprelis began surfacing in late May of 2011. DuPont has issued a warning letter to landscaping professionals urging them to not apply Imprelis near Norway Spruce or White Pine trees while the company investigates the reports. Additionally, the EPA is launching an investigation into tree death and damage reports in Minnesota, Indiana, Illinois, Ohio, Michigan, Pennsylvania, Maryland, Delaware and West Virginia. According to the lawsuit, Ohio appears to be the epicenter of the damage, since the chemical has been applied to thousands, if not tens of thousands, of lawns and other properties throughout Ohio.

“The manufacturers of this product, which was touted as being ‘environmentally friendly’, have some explaining to do,” remarked Arsenault. “The public deserves to know whether this product is safe and all of the consequences associated with its use.”

According to the lawsuit, victims began to notice trees located in the proximity of Imprelis application sites were yellowing, losing canopy and dying. They are seeking damages against DuPont in a lawsuit that was filed in the United States District Court for the Northern District of Ohio, Eastern Division.

US Government Bans Sale and Resale of Dangerous Drop-Side Cribs

Neblett Beard & Arsenault — Tue, 28 Jun 2011 15:38:38 +0000

Kudos to the U.S. CPSC for banning the sale, resale and manufacture of all drop-side cribs in the United States. Since 2000, 30 infants and toddlers have died as a result of these dangerous cribs, and this action will help prevent additional children from this cruel fate. Beginning today, all cribs sold in the U.S. must meet new, rigorous safety standards.

Most manufacturers have already gotten on board and are providing U.S. families with new and improved safety designs. However, no one knows exactly how many drop-side cribs are still out there. Since 2007, over 11 million of these types of cribs have been recalled due to their potential danger, but countless babies may still be at risk because of the use of second-hand or hand-me-down cribs with drop-sides. If you have questions or concerns, check out the CPSC website for questions and answers about crib safety.

At Neblett, Beard & Arsenault, we have seen first-hand the devastation, pain and destruction that these cribs can inflict on a family. Please help spread the word about the realities of drop-side cribs and encourage friends and family to make informed decisions when purchasing a new crib.

FDA Files Permanent Injunction Against Makers of Tainted Alcohol Wipes

Neblett Beard & Arsenault — Mon, 13 Jun 2011 16:41:10 +0000

In a press release, the U.S. Food and Drug Administration announced that a consent decree of condemnation, forfeiture, and permanent injunction has been filed against H&P Industries Inc., The Triad Group Inc., and three individuals who were responsible for producing and distributing s potentially contaminated with Bacillus cereus. Millions of products with the brand names of Triad Group,Cardinal Health, PSS Select, VersaPro, Boca/ Ultilet, Moore Medical, Walgreens, CVS and Conzellin were affected by the nation-wide recall.

Triad Group and H&P Industries of Hartland, Wisconsin, are accused of violiating good manufacturing standards and failing to heed FDA inspections and warnings about problems with contamination and sterility. Today’s actions mean that these groups cannot resume manufacturing and distributing drugs or medical devices until they establish an acceptable Quality Assurance and Quality Control program to ensure that all products manufactured in their facilities comply with federal standards for quality and have the identity, purity, potency and safety they are expected or are represented to possess. Additionally, about $6 million worth of products were seized by federal health officials over public safety fears.

Triad Group and H&P Industries have been sued by a Houston couple who blame the tainted pads for the death of their two-year-old son. The boy, who recently underwent surgery, was treated at the hospital with alcohol that were later recalled. The boy developed an infection with Bacillus cereus, and later died.

Arsenault to Speak at Hip Implant Litigation Conference

Neblett Beard & Arsenault — Wed, 11 May 2011 14:31:55 +0000

Richard Arsenault, senior partner of Neblett, Beard & Arsenault, has accepted an invitation to speak at this weekend’s g DePuy Pinnacle Hip Implant Litigation Conference in Louisville, KY. The conference is sponsored by HarrisMartin Publishing and takes place on the eve of the the Judicial Panel on Multidistrict Litigation’s hearing on a motion to consolidate the nation’s Pinnacle Hip cases.

Arsenault, who holds a spot on the Plaintiffs’ Steering Committee (PSC) for the DePuy ASR Hip litigation, is a veteran of class actions and complex litigation. He will present “Multidistrict Status Update” along with David R. Cohen, a Federal Special Master from Cleveland, OH; and Lawrence L. Jones, II, of Jones Ward PLC in Louisville, KY.

Arsenault’s firm is actively investigating claims against DePuy Orthopaedics and its parent company, Johnson & Johnson, for potentially faulty hip implants. He and his partners are frequent speakers and chairs of litigation conferences throughout the United States and Canada. Additionally, Arsenault is a recognized author, is frequently quoted by national news media, and will being teaching Advanced Litigation courses at LSU’s Paul M. Herbert Law Center this fall.

FDA Warns Hand Sanitizer Companies: Stop ‘Unproven’ MRSA Claims

Neblett Beard & Arsenault — Wed, 04 May 2011 13:16:23 +0000

The U.S. Food and Drug Administration announced that it issued Warning Letters to four companies that manufacture or distribute types of hand sanitizers and antiseptic products that inaccurately claim that they can prevent MSRA infections. The following four companies were issued Warning Letters:

1. Staphaseptic First Aid Antiseptic/Pain Relieving Gel, by Tec Laboratorie
2. Safe4Hours Hand Sanitizing Lotion and Safe4Hours First Aid Antiseptic Skin Protectant, by JD Nelson and Associates
3. Dr. Tichenor’s Antiseptic Gel, by Dr. G.H. Tichenor Antiseptic Co.
4. Clean Well All-Natural Hand Sanitizer, Clean Well All-Natural Hand Sanitizing Wipes, and Clean Well All-Natural Antibacterial Foaming Hand Soap, by Oh So Clean Inc., also known as CleanWell Company.

The FDA is concerned that these products are giving consumers a false sense of protection. Unproven claims found on product labels include, but are not limited to such claims as “kills over 99.9% of MRSA”; “helps prevent skin infections caused by MRSA and other germs”; “is effective against a broad spectrum of pathogens, including MRSA.”

MSRA is a very serious problem. It is a bacterium that can cause severe infections that may become life-threatening. Most troubling is that these infections do not respond to standard treatment with the antibiotic methicillin. According to Edward Cox, M.D., M.P.H., director of the FDA Office of Antimicrobial Products, MRSA is extremely difficult to treat.

Update on Meds IV and Possible Serratia Marcescens Contamination

Richard Arsenault — Thu, 31 Mar 2011 16:04:15 +0000

The Alabama Department of Public Health today is announcing an ongoing investigation of an outbreak of Serratia marcescens bacteremia in six Alabama hospitals. On March 16, ADPH was notified that an outbreak had occurred in two of these hospitals among patients receiving TPN (total parenteral nutrition).

TPN is liquid nutrition fed through an IV using a catheter. Use of contaminated products may lead to bacterial infection of the blood.

ADPH requested assistance from the Centers for Disease Control and Prevention. CDC’s initial investigation identified TPN produced by a single pharmacy, Meds IV, as a potential common source and has determined that these hospitals received TPN from this pharmacy. Affected hospitals are Baptist Princeton, Baptist Shelby, Baptist Prattville, Medical West, Cooper Green Mercy and Select Specialty Hospital in Birmingham.

Meds IV was notified and informed its customers of the possibility of contamination. ADPH has been informed that impacted hospitals immediately stopped using TPN received from this pharmacy and that the pharmacy discontinued all production. On March 24, Meds IV recalled all of its IV compounded products. The U.S. Food and Drug Administration is aware of the voluntary recall. The pharmacy and the hospitals are cooperating with the investigation.

At this time, ADPH is aware of 19 cases in these six hospitals of Serratia marcescens bacteremia related to this outbreak.

ADPH will provide updates as more information becomes available.

Product List

Bronch Procedure Kit
Bupivacaine Epidural Bag
Cardioplegia Solutions
Cefazolin 2 gm Syringe
Dialysate Solution
Fentanyl /Ropivacaine Epidural Bag
Fentanyl/ Bupivacaine Epidural Bag
Folic Acid 1mg/0.2ml Syringe
Glycopyrrolate 0.2mg/ml 1ml in 3ml Syringe
Heparin IV Bags
Hydromorphone Intravia Bag
Hydromorphone PCA Syringe
Ketamine Syringe
Labetalol syringe
Lorazepam 2mg/ml syr
Meperidine 10mg/100ml NS(Intravia Bag)
Morphine 1mg/ml PCA 100ml Intravia Bag
Neostigmine 3mg Syringe
Nitroglycerin IV Bag
Nitroglycerin Syringe
Norepinehrine IV Bag
Oxytocin Bags
Sodium Chl 23.4% (4meq/ml) 10ml Syr
Succinylcholine 20mg/ml 5ml Syringe
TPN Solution
Vancomycin IV Bag

Serratia Marcescens Outbreak in Alabama Hospitals

Richard Arsenault — Wed, 30 Mar 2011 19:09:18 +0000

Intravenous (IV) fluids can supply much needed nutrients and hydration to an ill individual. Recently, however, in Alabama, nine patients have died. Investigators have discovered that these patients received contaminated IV fluids. The investigation has not yet definitively determined that the bacteria, serratia marcescens, caused the deaths, but this is one avenue currently being explored by the Alabama Department of Public Health, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA).

Six hospitals are currently involved in this Alabama serratia marcescens investigation. They include Select Specialty, Baptist Princeton, Baptist Shelby, Medical West,Cooper Green and Baptist Prattville. The Alabama Department of Public Health is aware of the Serratia marcescens associated illnesses. The IV fluid bags were produced by Meds IV out of Birmingham, Alabama. The company has since notified its customers of the potential problems and has discontinued production.

S. marcescens is a bacteria that grows well in moist environments. In rare instances, individuals who develop infections associated with S. marcescens can develop endocarditis, osteomyelitis, pneumonia, or meningitis.

Kaba Lock Litigation

Richard Arsenault — Tue, 29 Mar 2011 15:07:11 +0000

A magnet….. A lock which opens without keys – only buttons….. These are key elements in class action litigation currently at play. With Richard J. Arsenault serving as co-lead plaintiff’s counsel in the lawsuits against Simplex push-button locks , which were manufactured by Kaba, and utilized at hospitals, airports, casinos, banks, the Department of Defense and police departments. This litigation is shaping up to be an interesting story to follow.

Feeling safe in your home is an essential component of every person’s life. These locks can be bypassed with a $30 dollar magnet. These magnets which are easily accessible can now be used to bypass a person or business’ security system, leaving these individuals open to theft and vandalism.

Stay tuned as we keep you up to date on this constantly evolving lawsuit.

Richard J. Arsenault Interviewed by NY Times in Kaba Lock Litigation

Richard Arsenault — Mon, 28 Mar 2011 19:51:27 +0000

Attorney Richard J. Arsenault, senior partner of Alexandria, LA-based Neblett, Beard & Arsenault, has been selected to serve as co-lead counsel for plaintiffs in emerging class action litigation against the makers of Kaba Simplex Keyless locks. The following is an article which ran in the New York Times on March 27th. The article discusses current litigation concerning Kaba Simplex Keyless Locks and the fact that they can be bypassed with a small, easily accessible magnet.

Yeshai M. Kutoff was house-proud, having bought a home in Cleveland Heights, Ohio, for his family of five. And as an Orthodox Jew, he bought push-button locks for the doors — an accommodation for the Sabbath, when many of the devout do not carry keys.

Yeshai M. Kutoff had push-button locks installed at his home in Cleveland Heights, Ohio.

When a neighbor told him that the locks he had bought could be opened by a powerful magnet costing about $30, Mr. Kutoff was perturbed. “It does bother me that other people could easily figure it out,” he said. Mr. Kutoff did not buy a magnet to see for himself. “It doesn’t interest me to know how to break into my own lock,” he said.

If this were a problem with security software instead of errant bits of steel, a company could send out a patch. If this was someplace other than the United States in the 21st century, Mr. Kutoff might have called a locksmith. But because it is the United States in the 21st century, lawyers are involved.

And now, in a federal courthouse in Ohio, 11 lawsuits have been consolidated into one against Kaba, a lock industry leader whose Simplex push-button locks are used by hospitals, airports, casinos, banks, the Department of Defense and police departments.

The company markets the locks as part of their “strong, powerful security solutions” and calls the push-button locks vandal resistant; the plaintiffs’ lawyers say otherwise. In fact, they accuse Kaba of deceptive trade practices, common-law fraud, negligence and product liability.

They say the locks, which can cost less than $200 or more than $1,000, depending on the model, are defective by design. And they are demanding that the company replace the locks, pay compensatory damages and even turn over all profits made from the locks over the years.

Plaintiffs’ briefs suggest that the class includes “hundreds of thousands of persons and entities,” and the case already involves some big players in the legal community, including Richard J. Arsenault and Daniel E. Becnel Jr. of Louisiana and Mark J. Geragos of Los Angeles.

Mr. Arsenault, the co-lead counsel for plaintiffs in the litigation, called the locks insecure and said the problem was a “slow-motion disaster.”

Mark P. Miller, a lawyer for Kaba, has argued in court that the plaintiffs’ lawyers were “fear-mongering,” and he ridiculed the lawsuits as “another Happy Meals case” — a reference to a much-belittled class-action suit filed in California in December that accuses McDonald’s of using toys to lure children into unhealthy eating habits.

In court filings, Kaba argued that it had “never advertised or warranted in any way that any of its access control products are impenetrable.” Locksmiths learn techniques to defeat all kinds of locks, and “thieves and others who want to defeat locks can obtain the same tools and learn the same techniques locksmiths use,” the filings said. “Indeed, any thief — even the most clumsy — can use a sledgehammer, a pry bar or bolt cutter to bypass essentially any lock.”

In a statement, Mr. Miller added that the company had “never received any confirmed report of a break-in” because of a magnetic bypass, and that it heard about the potential for magnetic mischief only in August 2010. Kaba is preparing a free kit to modify the locks and make them magnet-proof, he said.

In an earlier hearing in the case, Mr. Miller argued that beating a push-button lock was not as simple or easy as the plaintiffs claimed. “My own personal research shows that it takes a magnet the size of a bagel to get the locks open,” he said. In fact, the magnet required is only a couple of inches square, and a video shows the magnet alongside a bagel for comparison.

Mr. Miller also argued in court that the magnet was unwieldy and too powerful for most people to use. “It’s a big, heavy thing that if you have it in your pocket, and you happen to walk by something that’s made out of metal, you will get stuck to it and have to call 911 to get your pants somehow removed to save yourself,” he said.

This month, lawyers for the plaintiffs showed a video in court as an informal briefing for the judge that countered some of Mr. Miller’s contentions. The video shows someone sliding a magnet against a lock and removing it with one hand. The magnet pulls a locking plate away from the mechanism, allowing the door handle or knob to turn freely. Once the magnet has been removed, the narrator says, the plate slides back into place, and there is no evidence that the mechanism has been bypassed.

To Mr. Arsenault, Kaba’s argument that no one has been harmed by the locks is a weak one. He said that “there’s no way to know that,” and that even if no one has yet been harmed, “it’s obviously irresponsible to wait for criminal activity to occur before warning the public and taking immediate corrective action.”

As for the company’s proposed fix, he said, “the devil is in the details.”

And while many might look askance at a lawsuit over locks, this is not the first. Kryptonite, the maker of distinctive U-shaped bicycle locks, settled a class-action lawsuit in 2004 when it was revealed that its cylindrical locks could be defeated with the barrel of a Bic pen. The company redesigned the locks and offered customers exchanges or vouchers.

Marc Weber Tobias, an expert on locks and security who is not working for the lawyers in the Kaba case at this time but has met with them, said, “This is a serious deal and affects lots of agencies.”

He wrote about the locks in his blog for Forbes.com after sending an alert to law enforcement agencies, security professionals and locksmiths. “This is a very significant issue, because they are playing a game of jeopardy with the protection of property and lives,” he said.

Mr. Tobias acknowledged that brute force could defeat any lock. But he said: “Nobody is concerned about someone walking into an airport or bank or credit card facility with a sledgehammer or crowbar. They are concerned, however, about an unauthorized individual or criminal bypassing the security of a facility in two seconds, covertly, with a magnet.”

Meanwhile, Mr. Kutoff said he would simply like to get his locks exchanged for something safer. “It’s something that everybody wants to do — put a good lock on your house,” he said.

“In a perfect world, the locksmith doesn’t have a job,” Mr. Kutoff said. “But it’s not a perfect world.”

Richard Arsenault to Speak at DePuy Hip Litigation Conference Today

Neblett Beard & Arsenault — Wed, 17 Nov 2010 14:37:18 +0000

Richard J. Arsenault, senior partner in Neblett, Beard & Arsenault will speak at HarrisMartin Publishing’s DePuy Hip Implant Litigation Conference today in Durham, North Carolina.

Earlier this year, DePuy Orthpaedics, a division of Johnson & Johnson, initiated a worldwide recall of its ASR hip replacement products because of higher-than-expected failure rates.

It has been reported that 1 in 8 patients implanted with the recalled hip systems will have to undergo revision surgery within 5 years.

Neblett, Beard & Arsenault has filed litigation against Johnson & Johnson DePuy and continues to investigate other claims against the makers of the recalled ASR hip replacement systems.